Cogstate Limited (ASX:CGS)
Australia · Delayed Price · Currency is AUD
2.350
-0.020 (-0.84%)
Feb 26, 2026, 3:45 PM AEST
Revenue by Segment
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Clinical Trials (incl. Precision Recruitment Tool & Research) | 50.58M | 39.44M | 36.05M | - | - | | | | | |
Clinical Trials (incl. Precision Recruitment Tool & Research) Growth | 28.24% | 9.41% | - | - | - | | | | | |
| 2.51M | 3.99M | 4.40M | 4.46M | 3.76M | | | | | |
Healthcare (Incl. Sport) Growth | -37.06% | -9.45% | -1.25% | 18.57% | 161.85% | | | | | |
Unallocated Administration | - | - | - | 53.09K | 10.19K | | | | | |
Unallocated Administration Growth | - | - | - | 420.84% | - | | | | | |
Clinical Trials (Incl. Precision Recruitment Tool) | - | - | - | 40.33M | 28.67M | | | | | |
Clinical Trials (Incl. Precision Recruitment Tool) Growth | - | - | - | 40.67% | 36.02% | | | | | |
| - | - | - | 195.51K | 259.90K | | | | | |
Research Solutions Growth | - | - | - | -24.78% | 0.05% | | | | | |
| 53.09M | 43.43M | 40.45M | 45.03M | 32.70M | | | | | |
| 22.25% | 7.36% | -10.18% | 37.73% | 43.59% | | | | | |
Source: S&P Global Market Intelligence.
